Raising funding for blood cancer and GvHD research



test logo

Press Release

4th Cancer and Bone Marrow Transplant Specialists in Cleveland

Conference Open to Both Cancer Survivors and Healthcare Professionals

Cleveland, Ohio — The Case Comprehensive Cancer Center and the Meredith A. Cowden Foundation are bringing a national educational conference on Graft vs. Host Disease (GvHD) to Cleveland on Friday, April 24, 2015, 7:30 a.m. to 5 p.m., at the Embassy Suites Cleveland-Rockside, 5800 Rockside Woods Blvd., Independence, Ohio.  GvHD is a life-threatening complication experienced by an estimated 60 percent of all leukemia and other blood cancer patients following bone marrow transplantation.

“This is the only event of its type focusing exclusively on GvHD,” said Gerald Cowden, Chairman of the Meredith A. Cowden Foundation. “It brings together the nation’s foremost physicians, surgeons, research scientists, educators and other specialists in the fields of hematology, oncology, bone marrow transplantation and immunology.  We believe the work of these individuals will lead to significant improvements in the lives of patients battling GvHD and its symptoms.”

Who Should Attend

The symposium is open to both the general public and healthcare professionals. It features two tracks:  a scientifically rigorous one for physicians and other medical practitioners, and a patient track focusing on bone marrow transplant recipients and their families.

Admission is free of charge for cancer survivors and their families.  Registration for healthcare professionals (includes CME credits), is $100 for physicians and pharmacists, $75 for nurses and other healthcare professionals and $25 for students.  Reservations are required for survivors, families, caregivers and healthcare professionals.  Online registration is available at www.gvhdsymposium.org.

Subject to be covered and participating research and medical institutions to be announced.

About the Meredith A. Cowden Foundation

Cleveland attorney Gerald Cowden, together with his family and a core group of dedicated supporters, founded the Meredith A. Cowden Foundation in 2007, after his daughter was diagnosed with acute myeloid leukemia (AML).  In its five years of existence, the foundation has raised more than $250,000 for research and patient funding.  For more information, visit the Website at http://cowdenfoundation.org/.